DOI:
10.1055/s-00000173
Neuroradiologie Scan
LinksClose Window
References
Malmstrom A, Gronberg BH, Marosi C. et al.
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.
Lancet Oncol 2012;
13: 916-926
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.